De Novo proteome analysis of genetically modified tumor cells by a metabolic labeling/azide-alkyne cycloaddition approach
Activin receptor type II (ACVR2) is a member of the transforming growth factor type II receptor family and controls cell growth and differentiation, thereby acting as a tumor suppressor. ACVR2 inactivation is known to drive colorectal tumorigenesis. We used an ACVR2-deficient microsatellite unstable...
Gespeichert in:
| Hauptverfasser: | , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
November 28, 2014
|
| In: |
Molecular & cellular proteomics
Year: 2014, Jahrgang: 13, Heft: 12, Pages: 3446-3456 |
| ISSN: | 1535-9484 |
| DOI: | 10.1074/mcp.M113.036665 |
| Online-Zugang: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1074/mcp.M113.036665 Verlag, lizenzpflichtig, Volltext: https://www.mcponline.org/content/13/12/3446 
|
| Verfasserangaben: | Seda Ballikaya, Jennifer Lee, Uwe Warnken, Martina Schnölzer, Johannes Gebert, and Jürgen Kopitz |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1735257184 | ||
| 003 | DE-627 | ||
| 005 | 20220818221900.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 201009s2014 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1074/mcp.M113.036665 |2 doi | |
| 035 | |a (DE-627)1735257184 | ||
| 035 | |a (DE-599)KXP1735257184 | ||
| 035 | |a (OCoLC)1341368673 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Ballikaya, Seda |e VerfasserIn |0 (DE-588)1033922064 |0 (DE-627)743671767 |0 (DE-576)381600513 |4 aut | |
| 245 | 1 | 0 | |a De Novo proteome analysis of genetically modified tumor cells by a metabolic labeling/azide-alkyne cycloaddition approach |c Seda Ballikaya, Jennifer Lee, Uwe Warnken, Martina Schnölzer, Johannes Gebert, and Jürgen Kopitz |
| 264 | 1 | |c November 28, 2014 | |
| 300 | |a 11 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 09.10.2020 | ||
| 520 | |a Activin receptor type II (ACVR2) is a member of the transforming growth factor type II receptor family and controls cell growth and differentiation, thereby acting as a tumor suppressor. ACVR2 inactivation is known to drive colorectal tumorigenesis. We used an ACVR2-deficient microsatellite unstable colon cancer cell line (HCT116) to set up a novel experimental design for comprehensive analysis of proteomic changes associated with such functional loss of a tumor suppressor. To this end we combined two existing technologies. First, the ACVR2 gene was reconstituted in an ACVR2-deficient colorectal cancer (CRC) cell line by means of recombinase-mediated cassette exchange, resulting in the generation of an inducible expression system that allowed the regulation of ACVR2 gene expression in a doxycycline-dependent manner. Functional expression in the induced cells was explicitly proven. Second, we used the methionine analog azidohomoalanine for metabolic labeling of newly synthesized proteins in our cell line model. Labeled proteins were tagged with biotin via a Click-iT chemistry approach enabling specific extraction of labeled proteins by streptavidin-coated beads. Tryptic on-bead digestion of captured proteins and subsequent ultra-high-performance LC coupled to LTQ Orbitrap XL mass spectrometry identified 513 proteins, with 25 of them differentially expressed between ACVR2-deficient and -proficient cells. Among these, several candidates that had already been linked to colorectal cancer or were known to play a key role in cell growth or apoptosis control were identified, proving the utility of the presented experimental approach. In principle, this strategy can be adapted to analyze any gene of interest and its effect on the cellular de novo proteome. | ||
| 700 | 1 | |a Lee, Jennifer |d 1984- |e VerfasserIn |0 (DE-588)1033921858 |0 (DE-627)743671376 |0 (DE-576)381600440 |4 aut | |
| 700 | 1 | |a Warnken, Uwe |d 1961- |e VerfasserIn |0 (DE-588)122830075 |0 (DE-627)706059484 |0 (DE-576)293437947 |4 aut | |
| 700 | 1 | |a Schnölzer, Martina |e VerfasserIn |0 (DE-588)1158026110 |0 (DE-627)1021753610 |0 (DE-576)503538213 |4 aut | |
| 700 | 1 | |a Gebert, Johannes |e VerfasserIn |0 (DE-588)1033923567 |0 (DE-627)743674731 |0 (DE-576)381600688 |4 aut | |
| 700 | 1 | |a Kopitz, Jürgen |e VerfasserIn |0 (DE-588)1033923397 |0 (DE-627)743674472 |0 (DE-576)16530393X |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Molecular & cellular proteomics |d Bethesda, Md. : The American Society for Biochemistry and Molecular Biology, 2002 |g 13(2014), 12, Seite 3446-3456 |h Online-Ressource |w (DE-627)342318276 |w (DE-600)2071375-7 |w (DE-576)264424549 |x 1535-9484 |7 nnas |a De Novo proteome analysis of genetically modified tumor cells by a metabolic labeling/azide-alkyne cycloaddition approach |
| 773 | 1 | 8 | |g volume:13 |g year:2014 |g number:12 |g pages:3446-3456 |g extent:11 |a De Novo proteome analysis of genetically modified tumor cells by a metabolic labeling/azide-alkyne cycloaddition approach |
| 856 | 4 | 0 | |u https://doi.org/10.1074/mcp.M113.036665 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 856 | 4 | 0 | |u https://www.mcponline.org/content/13/12/3446 |x Verlag |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20201009 | ||
| 993 | |a Article | ||
| 994 | |a 2014 | ||
| 998 | |g 1033923397 |a Kopitz, Jürgen |m 1033923397:Kopitz, Jürgen |d 910000 |d 912000 |d 50000 |e 910000PK1033923397 |e 912000PK1033923397 |e 50000PK1033923397 |k 0/910000/ |k 1/910000/912000/ |k 0/50000/ |p 6 |y j | ||
| 998 | |g 1033923567 |a Gebert, Johannes |m 1033923567:Gebert, Johannes |d 910000 |d 912000 |e 910000PG1033923567 |e 912000PG1033923567 |k 0/910000/ |k 1/910000/912000/ |p 5 | ||
| 998 | |g 1158026110 |a Schnölzer, Martina |m 1158026110:Schnölzer, Martina |d 140000 |e 140000PS1158026110 |k 0/140000/ |p 4 | ||
| 998 | |g 122830075 |a Warnken, Uwe |m 122830075:Warnken, Uwe |d 50000 |e 50000PW122830075 |k 0/50000/ |p 3 | ||
| 998 | |g 1033921858 |a Lee, Jennifer |m 1033921858:Lee, Jennifer |d 910000 |d 912000 |e 910000PL1033921858 |e 912000PL1033921858 |k 0/910000/ |k 1/910000/912000/ |p 2 | ||
| 998 | |g 1033922064 |a Ballikaya, Seda |m 1033922064:Ballikaya, Seda |d 910000 |d 910900 |e 910000PB1033922064 |e 910900PB1033922064 |k 0/910000/ |k 1/910000/910900/ |p 1 |x j | ||
| 999 | |a KXP-PPN1735257184 |e 3773969511 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"note":["Gesehen am 09.10.2020"],"name":{"displayForm":["Seda Ballikaya, Jennifer Lee, Uwe Warnken, Martina Schnölzer, Johannes Gebert, and Jürgen Kopitz"]},"type":{"media":"Online-Ressource","bibl":"article-journal"},"id":{"doi":["10.1074/mcp.M113.036665"],"eki":["1735257184"]},"recId":"1735257184","relHost":[{"physDesc":[{"extent":"Online-Ressource"}],"disp":"De Novo proteome analysis of genetically modified tumor cells by a metabolic labeling/azide-alkyne cycloaddition approachMolecular & cellular proteomics","title":[{"subtitle":"MCP","title":"Molecular & cellular proteomics","title_sort":"Molecular & cellular proteomics"}],"pubHistory":["1.2002 -"],"recId":"342318276","language":["eng"],"origin":[{"dateIssuedKey":"2002","dateIssuedDisp":"2002-","publisherPlace":"Bethesda, Md.","publisher":"The American Society for Biochemistry and Molecular Biology"}],"type":{"media":"Online-Ressource","bibl":"periodical"},"id":{"zdb":["2071375-7"],"eki":["342318276"],"issn":["1535-9484"]},"part":{"issue":"12","extent":"11","volume":"13","year":"2014","text":"13(2014), 12, Seite 3446-3456","pages":"3446-3456"},"note":["Gesehen am 23.05.25"],"name":{"displayForm":["The American Society for Biochemistry and Molecular Biology (ASBMB)"]},"titleAlt":[{"title":"MCP"},{"title":"Molecular and cellular proteomics"}]}],"language":["eng"],"origin":[{"dateIssuedDisp":"November 28, 2014","dateIssuedKey":"2014"}],"title":[{"title":"De Novo proteome analysis of genetically modified tumor cells by a metabolic labeling/azide-alkyne cycloaddition approach","title_sort":"De Novo proteome analysis of genetically modified tumor cells by a metabolic labeling/azide-alkyne cycloaddition approach"}],"person":[{"display":"Ballikaya, Seda","role":"aut","given":"Seda","family":"Ballikaya","roleDisplay":"VerfasserIn"},{"display":"Lee, Jennifer","role":"aut","given":"Jennifer","family":"Lee","roleDisplay":"VerfasserIn"},{"display":"Warnken, Uwe","role":"aut","family":"Warnken","given":"Uwe","roleDisplay":"VerfasserIn"},{"roleDisplay":"VerfasserIn","family":"Schnölzer","given":"Martina","role":"aut","display":"Schnölzer, Martina"},{"role":"aut","display":"Gebert, Johannes","roleDisplay":"VerfasserIn","given":"Johannes","family":"Gebert"},{"role":"aut","display":"Kopitz, Jürgen","roleDisplay":"VerfasserIn","given":"Jürgen","family":"Kopitz"}],"physDesc":[{"extent":"11 S."}]} | ||
| SRT | |a BALLIKAYASDENOVOPROT2820 | ||